Characteristics and outcomes of angiovac-assisted debulking of intracardiac masses, thrombi, and endocarditis.
Haris PatailMohiuddin CheemaRaymond McKayJoseph IngrassiaPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
AngioVac is a viable therapeutic strategy for select patients with intravascular and intracardiac right-sided masses including thrombi, emboli, or infective masses such as endocarditis.